RSVP Below
Expertise from Neurologist Kenneth Wogensen, MD
The search for a cure for Alzheimer’s is always evolving, and we’re excited to spread news of every step forward. Join us Dr. Kenneth K. Wogensen, board-certified neurologist with Arcadia Methodist Hospital shares the latest about medications that are shaping a brighter future for individuals and families affected by Alzheimer’s.
Learn about upcoming drug approval decisions, late-stage clinical trials, and the latest news about Leqembi® (FDA approved 2023) and Donanemab (FDA approved July 2024). After the presentation, join us for a Q&A session with Dr. Wogensen.
The Kensington is a leading senior living provider of best-in-class memory care, led by a talented team with an unwavering commitment to excellence. We are proud to be a trusted source of information about dementia and Alzheimer’s care.
Kenneth K. Wogensen, MD, is an experienced board-certified neurologist who has been providing expert care since 1988. He earned a medical degree from the University of California, Irvine, School of Medicine; completed his neurology residency at the University of San Diego School of Medicine; and participated in a fellowship in the Stanford Neurology Unit. He is a family-oriented physician who doesn’t just take care of the patient, but the entire family. He specializes in the medical management of dementia, Alzheimer’s disease, vertigo, myasthenia gravis, and seizures. He is currently affiliated with the Arcadia Methodist Hospital, serving as the director of the stroke program.
For questions about this event, please email Jodie Kendall, Director of Community Relations, at jkendall@kensingtonsl.com.
